Go to the profile of Repertoire Genesis

Repertoire Genesis

 
  • Japan

About Repertoire Genesis

We have a world's best unbiased gene analysis method of T cell receptor (TCR) and B cell receptor (BCR). Our technology makes it possible to evaluate treatment effects of cancer immune cell therapy, bone marrow transplantation, or immune check point inhibitors. Our platform technology can also be used for development of promising advanced medical technologies such as TCR gene therapy, CAR-T therapy, and antibody drug development.

Therapeutic Areas

Oncology

Technologies

Diagnostics Drug delivery

Company Type

Other

State of Ownership

Private

Influencer Of

Topics

Topics contributed to:

MedTech Dealmakers